Bayer HealthCare Pharmaceuticals

Related Content

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF).
News | Cardiovascular Clinical Studies
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure Treatment

February 15, 2024 โ€” Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...

Home February 15, 2024
arrow
COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies
COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease

September 12, 2017 โ€” Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...

Home September 12, 2017
arrow
Bayer Arterion contrast media Injector used to administer medical imaging contrast for CT scans.
Feature | Contrast Media| Dave Fornell
Recent Developments and Issues in Contrast Media

Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...

Home June 19, 2017
arrow
Medrad Intego PET Infusion System, recall
News | Nuclear Imaging
Bayer Recalls All of its Medrad Intego PET Infusion System Source Administration Sets

January 12, 2017 โ€” Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source ...

Home January 12, 2017
arrow
News
Rivaroxaban May Be Alternative to Vitamin K Antagonists in Treating AF Patients

September 2, 2014 โ€“ Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...

Home September 02, 2014
arrow
Technology
Bayer Launches New Jetstream XC and SC Atherectomy Catheters

August 29, 2013 โ€” Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has cleared two new ...

Home August 29, 2013
arrow
News
Bayer Enters Agreement to Expand Markets for Medrad Intego PET Infusion System

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission ...

Home March 05, 2013
arrow
Bayer AngioJet DVT
Feature | Dave Fornell
Catheter-Based Clot Busting Therapies

Catheter-based thrombectomy systems are increasingly being used to remove blood clots from vessels inside the body ...

Home February 04, 2013
arrow
Feature | Dave Fornell
An Introduction to Atherectomy Systems

Atherectomy devices are used in the cath lab to debulk lesions by cutting or laser ablating plaque, calcium and tissue ...

Home July 17, 2012
arrow
Technology
New Jetstream Atherectomy Catheter Creates Larger Lumen

June 22, 2012 โ€” Bayer HealthCare widens its portfolio of interventional solutions by introducing the Jetstream Navitus L ...

Home June 22, 2012
arrow
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now